TROZEL 2,5 MG TBL FLM 28

What is the maximum co-payment for TROZEL?

If the insurance company contributes, the maximum co-payment is 2 243,32 Kč. The maximum pharmacy price is 2 451,68 Kč. A pharmacy may provide the medicine for a lower price, but not for a higher price.

Does the medicine have reimbursement from public health insurance?

Yes, but check the specialization of the prescribing physician below (a so-called non-delegable prescription).

Does TROZEL have a counted co-payment set?

Yes, the medicine has a counted co-payment of 314,00 Kč. Learn more about the protective limit here.

How much does the insurance company pay for one dispensed reimbursed pack?

208,36 Kč.

Does the insurance company pay a higher amount in some cases?

No, the medicine has no increased reimbursement.

Does the medicine have an indication restriction?

1) V adjuvanci u postmenopauzálních pacientek s karcinomem prsu je lékem první volby tamoxifen. Inhibitory aromatáz jsou hrazeny v případě:
a) kontraindikace tamoxifenu
b) u pacientek se středním a vysokým rizikem relapsu (dle St. Gallen)
c) po 2-3 letech podávání tamoxifenu (switch aplikace)
d) po 5 letech podávání tamoxifenu (prodloužená adjuvance)
2) v paliativní léčbě metastatického onemocnění je lékem první volby tamoxifen. Inhibitory aromatáz jsou hrazeny v případě kontraindikace tamoxifenu nebo při relapsu do jednoho roku po ukončení léčby tamoxifenem.

Is it available without a medical prescription?

No, the medicine cannot be obtained without a prescription.

Which medical specialist may prescribe TROZEL?

clinical oncology, pediatric oncology and hematology, radiation oncology and oncogynecology

What is the composition of TROZEL?

Letrozol (2,5 mg), neznámá látka s kódem 17625, neznámá látka s kódem 14679, magnesium-stearát, neznámá látka s kódem 18157. More information about the composition can be found in the SPC, section 6.1.

Where can I find information about correct use of the medicine?

Which medicines are similar to TROZEL?

The medicine belongs to ATC group L02BG04 – LETROZOL. Medicines with the same active substance can be found here.

Who manufactures TROZEL?

Glenmark Pharmaceuticals s.r.o., Praha (CZ)

Is the medicine in shortage?

The latest report from the manufacturer is from 24. 8. 2021. Production was terminated with effect from 20. 10. 2021. The manufacturer lists medicines with the following code as a potential substitute: